The General Pharmaceutical Council (GPhC) has published the results of the common registration assessment for aspiring pharmacists held on 2 November, 2023.
An overall pass rate of 66 per cent was recorded this year, as compared to 56 per cent in 2022 and 61 per cent in 2021.
A total of 1,067 candidates took the registration assessment, held jointly by the GPhC and Pharmaceutical Society of Northern Ireland (PSNI), of which
700 candidates cleared the assessment
In 2022, 937 candidates sat the registration assessment of which 525 passed the assessment.
Commenting on the results, GPhC Director of Education and Standards, Mark Voce, said: "I would like to congratulate all those who passed the November
registration assessment and I look forward to them joining our register to continue to the next stage of their career.
"There will be candidates who unfortunately did not pass the assessment. If this is the case, the information on our website outlines all the possible
options of what to do next.
Pharmacy owners using NHS Business Services Authority (NHSBSA) Manage Your Service (MYS) portal are urged to complete the 2023/24 Community Pharmacy Assurance
Framework (CPAF) screening questionnaire which is available until midnight on Sunday (30 July).
The short screening questionnaire consists of 10 questions. Those who are not yet signed up to MYS will be able to complete the questionnaire online. The questions
will be published on the NHSBSA website shortly.
Once the screening questionnaires have been completed, NHS England will then select a small number of pharmacies for a monitoring visit and/or to complete the full
CPAF questionnaire.
Community Pharmacy England has published a short Briefing on the screening process. As the questions have not changed since 2022/23 the previous briefing is still
relevant.
After struggling with COVID, Hemant Petal is back to good health, and now he is on a mission to reduce "health inequalities".
Speaking at the SIGMA Conference 2023, he spoke about his new role as Clinical Lead, Health Inequalities and Population Health Management, SE Essex Alliance,
Essex ICB.
"So, my new role is outside pharmacy, nothing to do with pharmacy. But it is important, I feel that I share some of my insights about the work that I'm doing that
might benefit you," he said.
Elaborating on the role of integrated care boards (ICBs), he said that they are designed to enhance coordination and collaboration across different healthcare
providers and settings.
The representatives from hospitals, community services, retail and social care meet on a monthly basis to "look at where there are issues to be resolved, perhaps
what can be done to improve the healthcare services."
The Scottish government is planning to publish its review report on use of automated technology in community pharmacies by the end of 2023.
The technology being trialled as part of the pilot includes robotic process automation, automated medicine storage systems, barcode scanners and prescription
collection kiosks.
The evaluation, which started prior to the COVID-19 pandemic, is due to be completed at the end of November 2023.
Patricia Findlay, professor of work and employment relations at the University of Strathclyde, who was commissioned to produce the report, told The
Pharmaceutical Journal that the pilot pharmacies taking part in the scheme are all based in Scotland, but she didn't reveal their names.
The National Institute for Health and Care Excellence (NICE) has issued draft guidance on 'Evusheld' which is not recommended for vulnerable adult with high
risk of severe Covid-19 on Thursday (16 February).
The draft guidance is open for public consultation until 9 March 2023. The committee will consider any comments received at a meeting currently due to take place on
4 April 2023.
It comes after last month's decision by the US drug regulator to withdraw its emergency use authorisation for Evusheld as a preventative treatment for Covid-19,
which said there was insufficient evidence that Evusheld is effective against the dominant variants of Covid-19 in the US.
NICE's independent appraisal committee has reached the same conclusion having considered evidence which shows Evusheld is unlikely to prevent infection with most of
the variants circulating in the UK now and in the near future.
It has also announced that it is developing a new review process to update recommendations on the cost-effectiveness of Covid-19 treatments so they can be made
available more quickly to patients if they show promise against new variants and are found to be cost-effective.
Titan PMR, a pioneer of cutting pharmacy technology has set up additional new team of 12 staff to cater for a deluge of independent pharmacists investing in
new businesses.
The company is utilising the opportunity that is underway as large chains look to sell off or close their community pharmacies, offering an opportunity for
pharmacists looking to provide efficient dispensing and additional services.
In January this year Lloyds Pharmacy, which was bought by a private equity firm in 2022, announced plans to close all its 237 branches inside Sainsbury's stores over
the course of 2023. Currently, more than 5,500 of around 14,000 registered pharmacy premises across the UK are owned by corporates and supermarkets.
Titan PMR - an innovative, cloud-based system which manages end-to-end pharmacy workflow - has become the preferred software platform especially amongst first time
buyers who are keen to offer new services to patients. The new team at the Bristol-based company, hired to support this sector, sees its total workforce growing to
more than 50 staff.
Health Education England (HEE) has developed funded training offers for community pharmacists, including locums aiming to become independent prescribers.
Almost 3000 independent prescribing training places will be available to pharmacists from March 2023.
This training enables pharmacists to support patients from diagnosis to prescribing, and to provide advice and follow-up - while also helping them to feel confident
and prepared for the new challenges of their role.
Courses will be available between April 2023 and March 2024, with several universities offering multiple dates for cohort intakes. Start dates will depend on the
university provider.
Training will enable the provision of new models of care: supporting patients from diagnosis to prescribing, providing advice and follow-up, and preparing pharmacists
to provide clinical care, as pharmacy services become more widespread within emerging clinical pathways.
The Royal Pharmaceutical Society (RPS) in collaboration with Health Education England's Centre for Advancing Practice and the Centre for Pharmacy Post
Graduate Education (CPPE) will provide a pharmacy-specific professional development pathway for advanced pharmacist practice.
Successful completion of the pathway, assured through the RPS Core Advanced Pharmacist Curriculum assessment, will result in pharmacists being recognised by RPS
as an advanced pharmacist, along with the awarding of HEE's Centre for Advancing Practice's 'Advanced' digital badge, demonstrating the quality assurance of their
advanced practice preparation to patients, families, carers, and other healthcare professionals.
The first participants in a fully funded, supported e-portfolio pathway to recognise advanced pharmacist practice in England will get underway in March 2023
This new programme is an important step in creating a clear postgraduate career structure for pharmacists in England.
The innovative approach provides funding from HEE's Centre for Advancing Practice in 2023-24 for 300 pharmacists in England who are near to, or already practicing at,
an advanced level, to enable them to receive supervision and support in building their RPS Core Advanced e-Portfolio from CPPE's pharmacy education supervisors.
Northern Ireland will see changes in the regulatory landscape following the issuance of the Windsor Framework on 27th Feb 2023 and the corresponding EU
Commission proposal. An agreement, in principle, has been reached by the UK and EU.
The new path forward of the Windsor Framework marks a turning point in how both the UK and the EU will work together collaboratively and constructively to ensure
that the same medicines are available in Northern Ireland at the same time as they are in the rest of the United Kingdom.
Whilst this is a successful result for Northern Ireland patients, this is major change for companies that have made specific provisions in their supply chains for
Northern Ireland. The supply chains of companies where provisions and changes were made such as introduction of GB specific pack may be impacted as a result.
However, the burden on the UK Pharma supply chain will be eased.
Prime Minister Rishi Sunak walks with European Commission chief Ursula von der Leyen in Windsor on February 27, 2023
Pharma companies will need to carefully consider making changes within their processes and supply chains pending the issuance of clear guidance from the MHRA on
the regulation changes resulting from the Windsor Agreement and the corresponding EU Commission proposed regulatory changes associated with medicinal products
within the Northern Ireland market.
Smooth access to the EU market for Northern Ireland pharmaceutical and medical technology firms has been safeguarded within the constraints of the agreement. The
pragmatic dual-regulatory system protects business, patients and healthcare services, and reflects that it is an essential state function to maintain and oversee
the supply of medicines within the whole United Kingdom.
The new Flat Fee payment to roll out in April 2023 to all pharmacy contractors who dispense at least 101 items a month, up to a national total of £70m on an
annual basis.
"The value of the Flat Fee payment has now been determined at £533 per month and will be introduced in the April 2023 Drug Tariff," said the Pharmaceutical Services
Negotiating Committee (PSNC).
"As with all payments, the Flat Fee payments are subject to change throughout the year depending on the overall level of funding delivery to Community Pharmacies.
This will be carefully monitored by PSNC and DHSC, and any funding changes will be communicated to pharmacy contractors as soon as they are known," said PSNC.
Department of Health and Social Care (DHSC) has increased the rate of discount deduction for generics from 17.52 per cent to 20 per cent.
The Drug Tariff for April 2023 will contain changes to the discount deduction arrangements for pharmacy contractors, which will include- all concession lines to be
considered as Group Items for Discount Not Deducted i.e. DND or zero discount (ZD) items; and rate of discount deduction for generics to increase from 17.52% to 20%
The Pharmaceutical Services Negotiating Committee (PSNC) and DHSC agreed on the changes for all concession lines to be considered as Group Items for Discount Not
Deducted. Therefore from 1 April 2023, a new category will be introduced into Part II of the Drug Tariff 'Drugs for which discount is not deducted'.
However, the committee had rejected the changes in the rate of discount deduction for generics. It said, "Following pressure from NHS England, Ministers have now
chosen to impose changes to the previously agreed discount deduction arrangements, which come into effect from 1 April, and will be kept under review."
The National Pharmacy Association (NPA) Board has elected 14 Board members on Friday (30 March) that will govern the association for next two years.
Four new Board members have been elected while five previous members left the Board after serving their terms. The period April 2023 to March 2025 will see the
completion of the transition to the new Board structure.
The Board will meet again on Monday (24 April) to elect the Chair and other appointments.
Gareth Jones, Returning Officer for the NPA Board elections, said: "The NPA has undertaken a process of significant modernisation of organisational governance over
the past years. Key elements of this process include adopting modern new Articles of Association, reforming the structure of the Board and introducing term limits.
The process of electing the Board has also been changed so that half of the Board will be up for election every two years - which supports continuity and reduces the
risk of a loss of organisational memory."
"Recognising that the Board would already be losing a lot of organisational memory in 2023 with five members of Board standing down, the Board determined that three
individuals should be co-opted onto the new Board as the process of transformation continues. In March 2025, anyone that has served 12 years or more will be required
to stand down."
A survey of over six thousands pharmacies has revealed that the community pharmacy sector is buckling under growing cost and capacity pressures.
The survey conducted by the Pharmaceutical Services Negotiating Committee, which also involved two thousand community pharmacy confirms, rising costs, patient
demand and
medicine supply issues continue to grip the sector.
PSNC's 2023 Pharmacy Pressures Survey, run as a follow up to the 2022 pressures survey, provides clear comparative data showing the worsening situation across
the sector.
Govt must act now
The result of the survey indeed paints a bleak picture for community pharmacies and it is clear that without urgent action from government and the NHS this will
only get worse: more community pharmacies will either be forced to reduce the number of services they provide or, in the worst-case scenario, will be left with
no option but to close their doors for good.
The PSNC has urged the government to act now "to save our pharmacies, before it is too late for patients, the public, and the rest of the NHS".
"This year's survey clearly shows that community pharmacies are buckling under growing cost and capacity pressures," said PSNC Chief Executive Janet Morrison.
What will it take to get help from the government before an individual or sector breaks? Pharmacists raised questions after the Pharmaceutical Services
Negotiating Committee (PSNC)'s 2023 Pharmacy Pressures Survey confirmed the ongoing pressures and health issues faced by the pharmacies.
Pharmacists are not all shocked by the PSNC's survey report as they feel the same as what has been reported related to their businesses and health. They hope
the government listens and work with them to find resolutions.
"We are bullied into a corner," said Salim Jetha Chairman, Avicenna.
"Unlike other industries, we can't increase our prices. Most of the daily calls I get from Independents is about financial health of their business and any cost
cutting would be detrimental to patient care. Urgent holistic review is required."
Bristol pharmacist Ade Williams said: "The report is a dire indictment, and I would also warn, likely an underestimate of the extent and detrimental impact of the
ongoings pressures and squeeze on Community pharmacies."
"If the closest interface of the NHS to communities and patients is so distressed, what does that mean for those that need and depend on us? We are notoriously very
stoic, so this is a warning light, which, taken with workforce pressures, market-exit activity, and other reports raising concern about wellbeing and stress, must
beg the question; what will it take to get help before the sector and individuals break?" he questioned.
The survey results don't surprise Kent-based community pharmacist Amish Patel. He said, "I have been feeling exactly what has been reported for far too long. I'm
burnt out and would say beginning to suffer with my own health because of it. Now it's for PSNC to talk to government, and government to listen and work with us to
find resolutions."
The Department of Health and Social Care (DHSC) in recent response to the questions asked by members of the House of Lords addressed the concerning trend
of pharmacy closures in rural areas across the UK.
Led by The Bishop of St Albans, inquiries focused on the number of community pharmacies that had ceased operations over the past five years and the ongoing
financial challenges faced by those remaining in rural regions.
Lord Markham, the Parliamentary Under-Secretary for Health and Social Care, provided insights into the stark reality confronting rural communities.
Highlighting data as per Guide to applying the Rural Urban Classification to data (2019-2023) Markham illustrated the significant closure rates of rural
pharmacies compared to the limited number of new openings between 2019 and 2023.
The figures revealed a fluctuating trend over the past five years, indicating a dynamic landscape within rural pharmacy provision.
In a significant uptick reflecting growing awareness and acceptance of mental health challenges among new and expectant mothers, NHS records reveal a
striking surge in specialist support sought by over 57,000 new mothers over the past year.
This figure represents a substantial 33 per cent increase compared to the 2022 data findings indicating a heightened demand for perinatal mental health services
in England.
Last year, the number of women accessing perinatal mental health services was 43,053 individuals.
Specifically, between March 2023 and February 2024, a total of 57,170 women accessed these services, representing a significant rise from the 43,053 women who received support between March 2022 and February 2023.
Contextually, this surge in demand is significant given that approximately 600,000 women give birth in England each year.
A recent survey conducted by the British Society Attitudes (BSA) and published by the King's Fund and the Nuffield Trust highlighted people's satisfaction
with the National Health Services (NHS) to be a new record low since the survey's inception in 1983.
The latest findings that are based on the public satisfaction and opinion with the NHS and social care, and funding in the context of prominent national debate
about taxation and healthcare spending reveal the satisfaction with the NHS to have dwindled across all services and demographics in 2023.
Public contentment has sharply declined, with only 24 per cent expressing satisfaction in 2023, a significant drop from 2020.
Factors contributing to this dissatisfaction include prolonged waiting times for GP and hospital appointments, staffing shortages, and perceived inadequate
government spending.
The NHS's latest report on ambulance services in England for March 2024 reveals significant progress in response times for emergency calls across all
categories compared to recent months.
The Ambulance Quality Indicators (AQI) Statistical Note, released in April, underscores both improvements and persistent challenges within the sector.
Recent figures obtained from the Liberal Democratic party suggest ongoing struggles with response times, particularly for category two patients, which may
include individuals experiencing strokes or heart attacks requiring a response within 18 minutes.
Similarly, in November last year, ambulance waits for category 2 calls surged to their highest level since December 2022, reaching 93 minutes, after dropping
to 32 minutes in January 2023 according to the British Heart Foundation.
However, according to the latest statistical figures obtained from AQI, March 2024 witnessed the shortest average response times for all four categories of
emergency calls since August 2023.
Recent NHS data sheds light on the evolving landscape of fit note certification, indicating a gradual expansion of roles beyond traditional medical
practitioners to pharmacists and nurses.
This uptake in numbers coincides with the Department of Work and Pensions's (DWP) call for evidence in relation to fit note reform which will remain open
till 8 July 2024.
According to figures published by NHS Digital, during the nine-month period from April 2023 to December 2023, pharmacists certified a significant number of
fit notes.
Approximately 1.4 per cent of fit notes of the 8 million were issued by pharmacists while the rest were issued by the GP surgeries reflecting the impact
following legislative amendments in July 2022, which extended certification authority to pharmacists, nurses, occupational therapists, and physiotherapists.
In June 2022, the Pharmacists' Defence Association (PDA) advised pharmacists not to sign fit notes where the required therapeutic, diagnostic, or examination
skills lie outside their scope of competence.
The association remarked that healthcare professionals needed mandatory training under the Health Education England before they are fit to issue fitness notes
to the public.
With scarlet fever currently circulating in England, the UK Health Security Agency (UKSHA) has urged parents to remain vigilant for potential symptoms in
children.
Also known as scarlatina, it is an infectious disease triggered by group A strep bacteria that can lead to symptoms such as fever, a sandpapery rash, sore throat
and swollen tonsils.
The latest data published by the UKHSA showed that a total of 19,528 cases of scarlet fever were reported in the 2023/24 season, of which 12,176 cases occurring
between 1 January and 24 March 2024.
While the number of cases recorded this year is lower than those recorded during the same period in 2023, which totaled 15,933 cases, it exceeds the average for
the previous five years.
"Scarlet fever is a common childhood illness, although it can affect anyone of any age," said Dr Theresa Lamagni at UKHSA.
Parents are advised to contact their GP practice or NHS111 when their GP is unavailable, if they suspect they or their child are experiencing symptoms of scarlet
fever.